Fig. 2From: Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and MetabolomicsHistopathological sections of liver and lung on the 1st, 7th, 14th, and 30th day after intravenous injection of PB NPs at a 20 mg/kg dose. (Bar: 100 μm. Arrow: PB NPs)Back to article page